BeOne Medicines (ONC) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.18% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.66% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 23.70% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 29.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.20% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | 22.77% |
| Jun 30, 2025 | 15.44% |
| Mar 31, 2025 | 7.68% |
| Dec 31, 2024 | 15.82% |
| Sep 30, 2024 | 19.47% |
| Jun 30, 2024 | 26.38% |
| Mar 31, 2024 | 17.72% |
| Dec 31, 2023 | 18.94% |
| Sep 30, 2023 | 22.80% |
| Jun 30, 2023 | 27.14% |
| Mar 31, 2023 | 14.90% |
| Dec 31, 2022 | 23.99% |
| Sep 30, 2022 | 16.55% |
| Jun 30, 2022 | 25.49% |
| Mar 31, 2022 | 43.03% |
| Dec 31, 2021 | 27.40% |
| Sep 30, 2021 | 33.36% |
| Jun 30, 2021 | 42.50% |
| Mar 31, 2021 | 19.81% |
| Dec 31, 2020 | 29.00% |
| Sep 30, 2020 | 36.61% |
| Jun 30, 2020 | 39.46% |
| Mar 31, 2020 | 44.95% |
| Dec 31, 2019 | 47.71% |
| Sep 30, 2019 | 46.50% |
| Jun 30, 2019 | 74.89% |
| Mar 31, 2019 | 51.71% |
| Dec 31, 2018 | 57.68% |
| Sep 30, 2018 | 88.58% |
| Jun 30, 2018 | 163.22% |
| Mar 31, 2018 | 190.32% |
| Dec 31, 2017 | 317.08% |
| Sep 30, 2017 | 379.56% |
| Jun 30, 2017 | 451.13% |
| Mar 31, 2017 | 129.23% |
| Dec 31, 2016 | 82.06% |
| Sep 30, 2016 | -42.33% |
| Jun 30, 2016 | 41.21% |
| Mar 31, 2016 | 12.96% |